Literature DB >> 27010728

An elevated preoperative plasma fibrinogen level is associated with poor overall survival in Chinese gastric cancer patients.

Weijun Yu1, Yongfeng Wang1, Boming Shen2.   

Abstract

OBJECTIVE: To investigate the association between preoperative plasma fibrinogen level and overall survival (OS) in a cohort of Chinese gastric cancer patients who underwent gastrectomy.
METHODS: A retrospective cohort study was conducted among 1090 gastric cancer patients treated between January 2003 and December 2011 who were eligible for inclusion criteria. Plasma fibrinogen level was routinely measured before surgeries. The optional cut-off value for fibrinogen level was estimated by receiver operating characteristic (ROC) curve analysis. OS was evaluated using Kaplan-Meier curve. Univariate and multivariate Cox regression models were performed to determine correlations between preoperative plasma fibrinogen level and OS.
RESULTS: Enrolled subjects who returned for at least one follow-up visit had been followed for a median of 44.0 months (interquartile range, 62.0 months). An optimal cut-off value of 3.9g/L was determined for preoperative plasma fibrinogen level. Lymph node dissection method, tumor location, invasion depth, lymph node metastasis, differentiation, distant metastasis, CA199 and plasma fibrinogen level remained statistically significant with OS in multivariate analysis. Plasma fibrinogen level was significantly associated with age, tumor size, lymph node dissection method, invasion depth, lymph node metastasis, TNM stage and CEA.
CONCLUSIONS: Elevated preoperative plasma fibrinogen was independently associated with poor prognosis and may serve as a clinically useful biomarker for risk assessment and treatment choice in Chinese gastric cancer patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Gastric cancer; Overall survival; Plasma fibrinogen level

Mesh:

Substances:

Year:  2016        PMID: 27010728     DOI: 10.1016/j.canep.2016.03.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  18 in total

1.  Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer.

Authors:  Jing Zhang; Shu-Qi Li; Zhi-Hua Liao; Yu-Huan Jiang; Qing-Gen Chen; Bo Huang; Jing Liu; Yan-Mei Xu; Jin Lin; Hou-Qun Ying; Xiao-Zhong Wang
Journal:  Oncotarget       Date:  2017-09-06

2.  Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.

Authors:  Xiang Zhang; Qiang Long
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Authors:  Ombretta Repetto; Stefania Maiero; Raffaella Magris; Gianmaria Miolo; Maria Rita Cozzi; Agostino Steffan; Vincenzo Canzonieri; Renato Cannizzaro; Valli De Re
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

4.  High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients.

Authors:  Weiwei Gao; Fei Zhang; Tai Ma; Jiqing Hao
Journal:  J Gastric Cancer       Date:  2020-05-06       Impact factor: 3.720

5.  Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.

Authors:  Hua-Xia Cai; Xu-Qi Li; Shu-Feng Wang
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

Review 6.  Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis.

Authors:  Guanqun Huang; Hui Jiang; Ye Lin; Yanpeng Wu; Weilong Cai; Boyun Shi; Yuanwei Luo; Zhixiang Jian; Xinke Zhou
Journal:  Cancer Manag Res       Date:  2018-10-29       Impact factor: 3.989

7.  Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma.

Authors:  Ju Bai; Yun Yang; Jianli Wang; Lei Zhang; Fangxia Wang; Aili He
Journal:  Clin Proteomics       Date:  2019-04-23       Impact factor: 3.988

8.  A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements.

Authors:  Julia Eberle; Rahel Stefanie Wiehe; Boris Gole; Liska Jule Mattis; Anja Palmer; Ludger Ständker; Wolf-Georg Forssmann; Jan Münch; J Christof M Gebhardt; Lisa Wiesmüller
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

9.  Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients.

Authors:  Shuang Fu; Zhi-Yuan Yun; Ming-Ming Cui; Hongxue Meng; Cheng Qian; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Oncotarget       Date:  2017-06-29

10.  Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy.

Authors:  Peng Ding; Chen Zheng; Guohui Cao; Ziming Gao; Yuying Lei; Peng Deng; Bin Hou; Kai Li
Journal:  Cancer Med       Date:  2019-05-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.